Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Alzheimer Disease × Hypnosis × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Neoplasms 6 Anxiety Disorders 6 Head and Neck Neoplasms 3 Depression 3 Chronic Pain 2 Xerostomia 1 Vomiting 1 Uterine Cervical Neoplasms 1 Tendinopathy 1 Smoking Cessation 1 Sleep Wake Disorders 1 Radiculopathy 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Pathophobia 1 Pain, Postoperative 1 Pain 1 Ovarian Neoplasms 1 Nociceptive Pain 1 Neuralgia, Postherpetic 1 Neuralgia 1 Nausea 1 Myocarditis 1 Musculoskeletal Pain 1 Melanoma 1 Medication Adherence 1 Lung Diseases, Interstitial 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1

Interventions

Dexamethasone 3 XENP 1595 2 Electroencephalography 2 pomalidomide 1 ixazomib 1 birtamimab 1 UE2343 1 Telemedicine 1 Tablets 1 Standard of Care 1 Rosiglitazone 1 Propofol 1 Positron-Emission Tomography 1 Methods 1 Melphalan 1 Mass Screening 1 Magnetic Resonance Imaging 1 Lysine Acetyltransferase 5 1 Hypnosis 1 Hormones 1 Exercise 1 Ethanol 1 Donepezil 1 Cyclophosphamide 1 Control Groups 1 Calcium Dobesilate 1 Bortezomib 1 Blood Specimen Collection 1 Amyloid 1 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06116084 2023-11-03

HYDEM

Central Hospital, Nancy, France

Phase NA Recruiting

Alzheimer Disease, Myocarditis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡